Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis

References

• Salamaco C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, Altrinetti V, Richiusa P, Gallazzo A, Giordano C. Regulation of apoptosis in endocrine autoimmunity. Ann NY Acad Sci 2002; 966: 496–501
   PubMed Web of Science ®Google Scholar
• Vaux D, Flavell RA. Apoptosis genes and autoimmunity. Cur Opin Immunol 2000; 12: 719–724
   PubMed Web of Science ®Google Scholar
• Andrikoula M, Tsatsoulis A. The role of Fas-mediated apoptosis in thyroid disease. Eur J Endocrinol 2001; 144: 561–568
   PubMed Web of Science ®Google Scholar
• Kroemer G, Zamzami N, Susin SA. Mitochondria control of apoptosis. Immunol Today 1997; 18: 44–51
   PubMedGoogle Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309–1312
   PubMed Web of Science ®Google Scholar
• Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 10: 369–377
   PubMed Web of Science ®Google Scholar
• Tsatsoulis A. The role of apoptosis in thyroid disease. Minerva Med 2002; 93: 169–180
   PubMedGoogle Scholar
• Mitsiades N, Poulaki V, Mitsiades CS, Koutras DA, Chrousos GP. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol Metab 2001; 12(9)384–390
   PubMed Web of Science ®Google Scholar
• Giordano C, Richiusa P, Bagnasco M, Pizzolanti G, Di Blasi F, Sbriglia MS, Mattina A, Pesce G, Montagna P, Capone F, Misiano G, Scorsone A, Pugliese A, Galluzzo A. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid 2001; 11(3)245–247
   PubMed Web of Science ®Google Scholar
• Wei Y, Chen K, Sharp GC, Yagita H, Braley-Mullen H. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatosus experimental autoimmune thyroiditis. J Immunol 2001; 167: 6678
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Hoshino T, Yagita H, Koga M, Sakisaka S, Honda J, Yang D, Kayagaki N, Okumura K, Nonaka K. Functional Fas ligand expression in thyrocytes from patients with Graves' disease. J Clin Endocrinol Metab 1999; 84: 2896–2902
   PubMed Web of Science ®Google Scholar
• Kawakami A, Eguchi K. Involvement of apoptotic cell death in autoimmune diseases. Med Electron Microsc 2002; 35: 1–8
   PubMedGoogle Scholar
• Rasmussen AK, Feldt-Rasmussn U, Brandt M, Hartoft-Nielsen ML, Carayon P, Buschard K. Thyrotropin stimulates specifically the expression of the autoantibody binding domains of the thyroperoxidase molecule. Autoimmunity 1999; 29(4)323–331
   PubMed Web of Science ®Google Scholar
• Bossowski A, Stasiak-Barmuta A, Czarnocka B, Urban M, Dadan J. Application of mAbs for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry. Autoimmunity 2005; 38(8)1–7
   PubMed Web of Science ®Google Scholar
• Stassi G, Todaro M, Bucchieri F, Stoppacciaro A, Farina F, Zummo G, Testi R, De Maria R. Fas/Fas ligand-driven T cell apoptosis as a conseqence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J Immunol 1999; 162: 263–267
   PubMed Web of Science ®Google Scholar
• Weetman AP, McGregor AM. Autoimmune thyroid disease: Further developments in our understanding. Endocr Rev 1994; 15: 788–830
   PubMed Web of Science ®Google Scholar
• Costagliola S, Many MC, Denef JF, Pohlenz J, Refetoff S, Vassart G. Genetic immunization of out bred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Incest 2000; 105: 803–811
   PubMed Web of Science ®Google Scholar
• Pujol-Borrell R, Todd I, Londei M, Feldmann M, Bottazzo GF. New ideas in thyroid autoimmunity. Horm Res 1987; 26: 118–124
   PubMedGoogle Scholar
• Baker JR, Jr. The nature of apoptosis in the thyroid and the role it may play in autoimmune thyroid disease. Thyroid 2001; 11: 245–247
   PubMedGoogle Scholar
• Stassi G, Zeuner A, Di Liberto D, Todaro M, Ricci-Vitiani L, De Maria R. Fas/FasL in Hashimoto's thyroiditis. J Clin Immunol 2001; 21: 19–23
   PubMed Web of Science ®Google Scholar
• Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960–963
   PubMed Web of Science ®Google Scholar
• Heuer M, Aust G, Ode-Hakim S, Scherbaum WA. Different cytokines mRNA profiles in Graves' disease, Hashimoto's thyroiditis and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 1996; 6: 97–106
   PubMed Web of Science ®Google Scholar
• Stassi G, Zeuner A, Di Liberto D, Todaro M, Ricci-Vitiani L, De Maria R. Fas/FasL in Hashimoto's thyroiditis. J Clin Immunol 2001; 21: 19–23
   PubMed Web of Science ®Google Scholar
• Stassi G, De Maria R. Autoimmune thyroid disease: New models of cell death in autoimmunity. Nat Rev Immunol 2002; 2: 195–204
   PubMed Web of Science ®Google Scholar
• Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Urayama S, Kawabe Y, Tahara K, Ishikawa N, Ito K, Nagataki S. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema. Clin Exp Immunol 1997; 110: 434–439
   PubMed Web of Science ®Google Scholar
• Mihara S, Suzuki N, Wakisaka S, Suzuki S, Sekita N, Yamamoto S, Saito N, Hoshino T, Sakane T. Effects of thyroid hormones on apoptotic cell death of human lymphocytes. J Clin Endocrinol Metab 1999; 84: 1378–1385
   PubMed Web of Science ®Google Scholar
• De Maria R, Testi R. Fas–FasL interactions: A common pathogenetic mechanizm in organ-specific autoimmunity. Immunol Today 1998; 19: 121–125
   PubMedGoogle Scholar
• Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM. Dominant interfering Fas gene mutations impair apoptosis in a human lymphoproliterative syndrome. Cell 1995; 81: 935–946
   PubMed Web of Science ®Google Scholar
• Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347–1349
   PubMed Web of Science ®Google Scholar
• Bona G, Defranco S, Chiocchetti A, Indelicato M, Biava A, Difranco D, Dianzani I, Ramenghi U, Corrias A, Weber G, De Sanctis V, Iughetti L, Radetti G, Dianzani U. Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diesases. Clin Exp Immunol 2003; 133: 430–437
   PubMed Web of Science ®Google Scholar